logo

Low cost tracking and data management solution for biopharma cold chain logistics

Sector: Hospital • Location: Denmark

Source: EU Funding & Tenders Portal

Project
Ended

The Danish company Globe Tracker International (GT) is revolutionizing supply chain visibility and profitability as a leading provider of data sharing, data analytics and global asset tracking. GT has developed a fully functional hardware/data management system that is ready to be deployed globally and is currently being tested in commercial trials in the reefer market. GT has partnered with globa

Project Information FAQ

Project Information

3 Q
The project “Low cost tracking and data management solution for biopharma cold chain logistics” is an infrastructure initiative in the Hospital sector, located in Denmark. Taiyo aggregates data on it from EU Funding & Tenders Portal.

Want to explore the full details? View the full report

Participants

Sponsoring Agency

Obfuscated Data

Company

Obfuscated Data

Status

Original status

ended

Taiyo status

Obfuscated Data

Taiyo last update

00-00-0000

Available timestamps

00-00-0000

Available timestamp type

Obfuscated Data

Contact

Contact name

Obfuscated Data

Phone

0000000000

Email

ObfuscatedData@email.com

Address

Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data

Description

Description

The Danish company Globe Tracker International (GT) is revolutionizing supply chain visibility and profitability as a leading provider of data sharing, data analytics and global asset tracking. GT has developed a fully functional hardware/data management system that is ready to be deployed globally and is currently being tested in commercial trials in the reefer market. GT has partnered with global OEMs, container manufacturers and data transmission companies to help commercial expansion. For this project, GT has identified the the pharma product delivery market as a high value segment in which demand exists but where its solution needs adaptation to meet customer and regulatory requirements. The demand stems from the need for safe, secure and efficient distribution of pharma products in a strictly controlled and refrigerated environment in order to protect the integrity of the drugs. Today temperature deviations endanger patient safety and increase costs. In addition, sabotage and counterfeiting damages safety and brand values. This need is especially apparent in the fast growing biologics market that already represents a third of blockbuster pharma shipments and over half of clinic trials. The feasibility study will (1) identify the most promising pharma market niche for entry that will ultimately open up growth into all other temperature/security/counterfeit relevant segments and (2) define the technical design for its final products to deliver the largest possible economic benefits to the supply chain. The feasibility study will help to understand how the multi-layered stakeholders need to be involved. GT will evaluate the competitive landscape, analyse pricing and ROI models and monitor its FTO position, while it is building a patent portfolio throughout Phase1 and Phase 2. The succesful outcome of the Phase II project will reduce product loss by 25%, reduce the influx of counterfeit by 50% and ensure compliance with recent EU and US logistics regulations.

Original sub-sector

Obfuscated

Original Currency

USD

Original budget

000000000000000

Procurement method

Obfuscated Data

Budget

000000000000000

Location

Region

Obfuscated

Country

Obfuscated

State

Obfuscated Data

County

Obfuscated

Location

Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data

Source

Source reliability

High

Data quality score

100%

Source

Obfuscated Data

URL

obfuscated_data,obfuscateddata.com

More Details

Project Type

Obfuscated Data

Article Published Date

Obfuscated Data